ENVB- Enveric Biosciences, Inc.

Name: Enveric Biosciences, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Enveric Biosciences, Inc. (ENVB) has 8 insiders with recent SEC Form 4 filings, including 6 buys and 38 sells. ENVB is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Tucker Joseph Edward	70.4K	$201.2K	-
CFO	Coveney Kevin Michael	47.4K	$135.6K	-
Other	Facchini Peter J.	33.1K	$94.5K	-
Dir	Pasqualone Frank	7.9K	$22.6K	-
Dir	Schabacker Marcus	7.9K	$22.6K	-

Activity

Buys and sells only

Transactions

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Sep 15, 2023	Pasqualone Frank	Director	Buy	1,000	$2.14	$2,140.00	New	-35.5%	-78.0%
Nov 16, 2018	Sikaria Family 2008 Revocable Trust Dated 02/28/2008	10% Owner	Sell	100,000	$0.30	$29,549.64	-0.5%	-	-
Nov 16, 2018	Sikaria Lokesh	10% Owner	Sell	100,000	$0.30	$29,549.64	-0.5%	-	-
Nov 16, 2018	Lokesh Sikaria Trust Dated 12/14/2012	10% Owner	Sell	100,000	$0.30	$29,549.64	-0.5%	-	-
Nov 16, 2018	Sikaria Chanda	10% Owner	Sell	100,000	$0.30	$29,549.64	-0.5%	-	-
Jul 17, 2018	Devanur Giri	10% Owner	Sell	429,357	$2.07	$887,945.92	-10.6%	-	-
Nov 17, 2017	Devanur Giri	President &CEO	Buy	12,121	$4.12	$49,877.92	+0.6%	-	-
Nov 17, 2017	Rai Dhruwa N	Director	Buy	145,450	$4.12	$598,526.75	+28.9%	-	-
Nov 17, 2017	Eberwein Jeffrey E.66	Director, 10% Owner	Buy	100,000	$4.12	$411,500.00	+3.5%	-	-
Oct 30, 2017	Eberwein Jeffrey E.66	Director, 10% Owner	Buy	3,803	$6.50	$24,718.72	+16.7%	-	-

Page 1Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC